ILK and breast cancer: Moreover, ILK has been shown to bind to estrogen receptor-alpha (ERα) both in in vitro and in vivo studies [44] and, in fact, it seems that ILK signaling is a modulator of ER signaling in BC, with major consequences for BC patients, as ER status is an important feature that greatly determines the patients’ treatment and, sometimes, fate.